Nelsen M R, Dunner D L
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle.
Psychiatr Clin North Am. 1993 Sep;16(3):541-66.
The disorders discussed in this article share common problems with treatment-resistant depression both in research and clinical treatment. Lack of clear treatment-resistant definitions leads to difficulties in comparing the results of research studies. The absence of double-blind, placebo-controlled studies that match alternative treatments against each other creates confusion for the clinician who has to decide on a treatment paradigm. The future will, no doubt, see an increase in interest in treatment-resistant research and the answer to some of these questions. Although this review emphasizes the work that remains to be done before treatment resistance becomes a curiosity of the past, it also highlights the wealth of treatment options available to clinicians and their patients. As long as treatment-resistant patients are amendable to trying new therapies, hope that their depressions will lift remains.
本文所讨论的疾病在研究和临床治疗方面与难治性抑郁症都存在共同问题。缺乏明确的难治性定义导致研究结果难以比较。缺乏相互匹配替代疗法的双盲、安慰剂对照研究,给必须决定治疗方案的临床医生造成了困惑。毫无疑问,未来人们会对难治性研究更感兴趣,其中一些问题也会得到解答。尽管本综述强调在难治性成为过去式之前仍有待开展的工作,但它也凸显了临床医生及其患者可获得的丰富治疗选择。只要难治性患者愿意尝试新疗法,他们的抑郁症有望缓解的希望就依然存在。